Top Official Warned That Covid Vaccine Plant Had to Be ‘Monitored Closely’

An Operation Warp Speed report last June flagged staffing and quality control concerns at Emergent BioSolutions’ factory in Baltimore. The troubled plant recently had to throw out up to 15 million doses.

#astrazeneca-plc, #baltimore-md, #biden-joseph-r-jr, #coronavirus-2019-ncov, #drugs-pharmaceuticals, #emergent-biosolutions-inc, #government-contracts-and-procurement, #johnsonjohnson, #novavax-inc, #public-private-sector-cooperation, #stockpiling, #trump-donald-j, #vaccination-and-immunization

0

Virus Variants Threaten to Draw Out the Pandemic, Scientists Say

Declining infection rates over all masked a rise in more contagious forms of the coronavirus. Vaccines will stop the spread, if Americans postpone celebration just a bit longer.

#astrazeneca-plc, #brazil, #coronavirus-2019-ncov, #disease-rates, #europe, #florida, #germany, #great-britain, #immune-system, #influenza, #johnsonjohnson, #moderna-inc, #novavax-inc, #oxford-university, #pfizer-inc, #vaccination-and-immunization, #your-feed-science

0

Can the World Learn From South Africa’s Vaccine Trials?

Vaccine trials are often done in wealthier countries. Scientists say the South Africa experience proves the value of trials in the global south.

#astrazeneca-plc, #clinical-trials, #coronavirus-2019-ncov, #disease-rates, #gates-bill-and-melinda-foundation, #novavax-inc, #oxford-university, #south-africa, #third-world-and-developing-countries, #vaccination-and-immunization

0

U.S. and Novavax Will Aid Global Vaccination Campaign

The Biden administration plans to make good on a promise to donate $4 billion, while the pharmaceutical company Novavax committed to sell 1.1 billion doses of its vaccine.

#biden-joseph-r-jr, #coronavirus-2019-ncov, #foreign-aid, #gavi-the-vaccine-alliance, #novavax-inc, #philanthropy, #united-states-international-relations, #united-states-politics-and-government, #vaccination-and-immunization

0

Covid Vaccines for Kids Are Coming, but Not for Many Months

Pfizer and Moderna are testing their vaccines on children 12 and older and hope to have results by the summer.

#children-and-childhood, #clinical-trials, #coronavirus-2019-ncov, #disease-rates, #immune-system, #johnsonjohnson, #moderna-inc, #novavax-inc, #parenting, #pfizer-inc, #research, #teenagers-and-adolescence, #vaccination-and-immunization, #your-feed-science

0

How New Vaccine News Gives Hope for Spring, if Enough People Get the Shots

New data from several vaccine trials offer positive signs, but many public health experts say emerging variants mean the next few months will be a race against the virus.

#astrazeneca-plc, #coronavirus-2019-ncov, #disease-rates, #johnsonjohnson, #medicine-and-health, #moderna-inc, #novavax-inc, #nursing-homes, #pfizer-inc, #third-world-and-developing-countries, #vaccination-and-immunization, #your-feed-healthcare

0

After a Rocky Start, Novavax Vaccine Could Be Here by Summer

Even with two other vaccines authorized, Novavax is having no trouble recruiting volunteers for its U.S. trial. If all goes well, the U.S. could see 110 million doses in June.

#black-people, #clinical-trials, #coronavirus-2019-ncov, #discrimination, #hispanic-americans, #novavax-inc, #race-and-ethnicity, #research, #vaccination-and-immunization, #your-feed-health

0

Which Covid Vaccine Should You Get? Experts Weigh the Effect Against Severe Disease

Infectious disease doctors say getting a shot of the J&J vaccine, which has a lower efficacy against the virus than other vaccines, would still be well worthwhile.

#astrazeneca-plc, #clinical-trials, #coronavirus-2019-ncov, #drugs-pharmaceuticals, #fauci-anthony-s, #johnsonjohnson, #moderna-inc, #novavax-inc, #pfizer-inc, #vaccination-and-immunization, #your-feed-healthcare

0

Novavax’s Vaccine Works Well — Except on Variant First Found in South Africa

An early analysis in Britain found that the vaccine had an efficacy rate of nearly 90 percent. But in a small South Africa trial, the efficacy rate dropped to just under 50 percent.

#clinical-trials, #coronavirus-2019-ncov, #novavax-inc, #vaccination-and-immunization, #your-feed-science

0

Governments Sign Secret Vaccine Deals: Here’s What They Hide

Multibillion-dollar contracts give drug makers liability shields, patent ownership and leeway on delivery dates and pricing — and promises that much of it will not be made public.

#astrazeneca-plc, #coalition-for-epidemic-preparedness-innovations, #coronavirus-2019-ncov, #government-contracts-and-procurement, #moderna-inc, #national-institutes-of-health, #novavax-inc, #pfizer-inc, #vaccination-and-immunization, #world-health-organization

0

U.S. and Pfizer Seal Deal for 100 Million More Vaccine Doses

The company agreed to deliver the additional doses of its coronavirus vaccine by the end of July, helping address a looming shortage.

#azar-alex-m-ii, #biontech-se, #coronavirus-2019-ncov, #coronavirus-aid-relief-and-economic-security-act-2020, #defense-production-act, #drugs-pharmaceuticals, #johnsonjohnson, #moderna-inc, #novavax-inc, #pfizer-inc, #sanofi-sa, #trump-donald-j, #vaccination-and-immunization

0

Pfizer Nears Deal to Provide More Vaccine Doses

The company could provide at least tens of millions of additional doses of a coronavirus vaccine under an agreement that would give it better access to the supplies it needs to expand manufacturing.

#astrazeneca-plc, #azar-alex-m-ii, #biontech-se, #bourla-albert, #coronavirus-2019-ncov, #defense-production-act, #drugs-pharmaceuticals, #johnsonjohnson, #moderna-inc, #novavax-inc, #perna-gustave-f, #pfizer-inc, #presidential-election-of-2020, #sanofi-sa, #trump-donald-j, #vaccination-and-immunization

0

How the Out-of-Control Pandemic Is Speeding the Hunt for Vaccines

The surge in coronavirus cases worldwide is helping researchers measure more quickly how well their vaccines protect against Covid-19.

#astrazeneca-plc, #clinical-trials, #coronavirus-2019-ncov, #drugs-pharmaceuticals, #johnsonjohnson, #moderna-inc, #novavax-inc, #pfizer-inc, #regeneron-pharmaceuticals-inc, #vaccination-and-immunization

0

The Coronavirus Vaccines Will Likely Work. Making Them Fast Will Be Hard.

Front-runners in the coronavirus vaccine race won’t make nearly as many doses this year as were predicted, but they may kick into high gear next year.

#astrazeneca-plc, #bourla-albert, #clinical-trials, #coronavirus-2019-ncov, #factories-and-manufacturing, #food-and-drug-administration, #johnsonjohnson, #moderna-inc, #novavax-inc, #pfizer-inc, #trump-donald-j, #united-states, #vaccination-and-immunization, #your-feed-science

0

Covid-19 Vaccines Offer Drug Makers Chance at Salvation, Financial and Beyond

Big profits beckon for pharmaceutical companies, which are already using their work on vaccines to fight efforts in Washington to curb drug prices.

#astrazeneca-plc, #clinical-trials, #coronavirus-2019-ncov, #curevac-gmbh, #drugs-pharmaceuticals, #glaxosmithkline-plc, #gorsky-alex, #johnsonjohnson, #merckcompany-inc, #novavax-inc, #pfizer-inc, #sanofi-sa, #vaccination-and-immunization

0

Novavax Enters Final Stage of Coronavirus Vaccine Trials

The Maryland company, which has never brought a vaccine to market, has started its Phase 3 trial in the United Kingdom, with plans to begin in the United States in October.

#clinical-trials, #coronavirus-2019-ncov, #drugs-pharmaceuticals, #great-britain, #influenza, #johnsonjohnson, #moderna-inc, #novavax-inc, #pfizer-inc, #research, #united-states, #vaccination-and-immunization

0

When Will You Be Able to Get a Coronavirus Vaccine?

Despite the president’s repeated claims that a vaccine will be available in October, scientists, companies and federal officials all say that most people won’t get one until well into next year.

#advisory-committee-on-immunization-practices, #astrazeneca-plc, #centers-for-disease-control-and-prevention, #clinical-trials, #coronavirus-2019-ncov, #food-and-drug-administration, #johnsonjohnson, #moderna-inc, #novavax-inc, #pfizer-inc, #redfield-robert-r, #shortages, #trump-donald-j, #united-states-politics-and-government, #vaccination-and-immunization

0

This Company Boasted to Trump About Its Covid-19 Vaccine. Experts Are Skeptical.

Inovio, a Pennsylvania biotech company, has spent years claiming to be on the cusp of important vaccines. It has never brought one to market.

#caplan-arthur-l, #clinical-trials, #coronavirus-2019-ncov, #defense-department, #dna-deoxyribonucleic-acid, #drugs-pharmaceuticals, #factories-and-manufacturing, #gates-bill-and-melinda-foundation, #health-and-human-services-department, #inovio-pharmaceuticals, #moderna-inc, #novavax-inc, #vaccination-and-immunization, #vaxart-inc

0

Novavax’s New Covid-19 Vaccine Studies Praised By Scientists

The company has received a $1.6 billion grant from the government’s Operation Warp Speed to have 100 million doses ready by early 2021.

#clinical-trials, #coronavirus-2019-ncov, #immune-system, #novavax-inc, #public-private-sector-cooperation, #research, #vaccination-and-immunization

0

Corporate Insiders Pocket $1 Billion in Rush for Coronavirus Vaccine

Well-timed stock bets have generated big profits for senior executives and board members at companies developing vaccines and treatments.

#armistice-capital, #coronavirus-2019-ncov, #drugs-pharmaceuticals, #floroiu-andrei, #moderna-inc, #novavax-inc, #regeneron-pharmaceuticals-inc, #vaccination-and-immunization, #vaxart

0

How Novavax Won $1.6 Billion From Operation Warp Speed For Coronavirus Vaccine

Novavax just received the Trump administration’s largest vaccine contract. In the Maryland company’s 33-year history, it has never brought a vaccine to market.

#biomedical-advanced-research-and-development-authority, #bright-rick-a, #clinical-trials, #coronavirus-2019-ncov, #emergent-biosolutions-inc, #factories-and-manufacturing, #gates-bill-and-melinda-foundation, #government-contracts-and-procurement, #hatchett-richard-j, #health-and-human-services-department, #influenza, #kadlec-robert-p, #novavax-inc, #public-private-sector-cooperation, #respiratory-syncytial-virus-rsv, #stocks-and-bonds, #united-states-politics-and-government, #vaccination-and-immunization

0

Novavax Gets $1.6 Billion for Coronavirus Vaccine From Operation Warp Speed

The Maryland-based company, which has never brought a product to market before, just made the biggest deal to date with the Trump administration’s Operation Warp Speed.

#astrazeneca-plc, #clinical-trials, #coalition-for-epidemic-preparedness-innovations, #coronavirus-2019-ncov, #johnsonjohnson, #moderna-inc, #novavax-inc, #vaccination-and-immunization, #your-feed-science

0